ClinicalTrials.gov record
Completed Phase 4 Interventional Results available

A Trial To Evaluate The Efficacy And Safety Of Fesoterodine In Patients With Symptoms Of Overactive Bladder Including Nocturnal Urinary Urgency

ClinicalTrials.gov ID: NCT00911937

Public ClinicalTrials.gov record NCT00911937. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 4, 2026, 5:46 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Double Blind, Placebo Controlled, Parallel Group, Multicenter Trial To Evaluate The Efficacy And Safety Of A Fesoterodine Flexible Dose Regimen In Patients With Symptoms Of Overactive Bladder Including Nocturnal Urinary Urgency.

Study identification

NCT ID
NCT00911937
Recruitment status
Completed
Study type
Interventional
Phase
Phase 4
Lead sponsor
Pfizer
Industry
Enrollment
963 participants

Conditions and interventions

Interventions

  • Fesoterodine Drug
  • Placebo Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jul 31, 2009
Primary completion
Aug 31, 2011
Completion
Aug 31, 2011
Last update posted
Dec 3, 2018

2009 – 2011

United States locations

U.S. sites
112
U.S. states
37
U.S. cities
102
Facility City State ZIP Site status
Pfizer Investigational Site Mobile Alabama 36608
Pfizer Investigational Site Goodyear Arizona 85395
Pfizer Investigational Site Litchfield Park Arizona 85340
Pfizer Investigational Site Phoenix Arizona 85020
Pfizer Investigational Site Tucson Arizona 85741
Pfizer Investigational Site Little Rock Arkansas 72205
Pfizer Investigational Site Fresno California 93720
Pfizer Investigational Site La Mesa California 91942
Pfizer Investigational Site Newport Beach California 92660
Pfizer Investigational Site Roseville California 95661
Pfizer Investigational Site Sacramento California 95825
Pfizer Investigational Site San Diego California 92103-6204
Pfizer Investigational Site San Diego California 92103
Pfizer Investigational Site San Diego California 92108
Pfizer Investigational Site Tarzana California 91356
Pfizer Investigational Site Denver Colorado 80218
Pfizer Investigational Site Denver Colorado 80220
Pfizer Investigational Site Farmington Connecticut 06032
Pfizer Investigational Site New Britain Connecticut 06052
Pfizer Investigational Site Norwalk Connecticut 06850
Pfizer Investigational Site Dover Delaware 19904
Pfizer Investigational Site Bonita Springs Florida 34134
Pfizer Investigational Site Brooksville Florida 34601
Pfizer Investigational Site DeFuniak Springs Florida 32435
Pfizer Investigational Site Destin Florida 32541
Pfizer Investigational Site Leesburg Florida 34748
Pfizer Investigational Site Naples Florida 34102
Pfizer Investigational Site Ocala Florida 34471
Pfizer Investigational Site Ocala Florida 34474
Pfizer Investigational Site Pembroke Pines Florida 33024
Pfizer Investigational Site South Miami Florida 33143
Pfizer Investigational Site St. Petersburg Florida 33709
Pfizer Investigational Site Tallahassee Florida 32308
Pfizer Investigational Site Tampa Florida 33606
Pfizer Investigational Site Atlanta Georgia 30329-5102
Pfizer Investigational Site Coeur d'Alene Idaho 83814
Pfizer Investigational Site Chicago Illinois 60634
Pfizer Investigational Site Chicago Illinois 60654
Pfizer Investigational Site Fort Wayne Indiana 46825
Pfizer Investigational Site Jeffersonville Indiana 47130
Pfizer Investigational Site Iowa City Iowa 52242
Pfizer Investigational Site West Des Moines Iowa 50266
Pfizer Investigational Site Newton Kansas 67114
Pfizer Investigational Site Overland Park Kansas 66202
Pfizer Investigational Site Overland Park Kansas 66210
Pfizer Investigational Site Overland Park Kansas 66211
Pfizer Investigational Site Pratt Kansas 67124
Pfizer Investigational Site Madisonville Kentucky 42431
Pfizer Investigational Site Mount Sterling Kentucky 40353
Pfizer Investigational Site Shreveport Louisiana 71106
Pfizer Investigational Site Annapolis Maryland 21401
Pfizer Investigational Site Fall River Massachusetts 02720
Pfizer Investigational Site Hyannis Massachusetts 02601
Pfizer Investigational Site Milford Massachusetts 01757
Pfizer Investigational Site New Bedford Massachusetts 02740
Pfizer Investigational Site Watertown Massachusetts 02472
Pfizer Investigational Site Troy Michigan 48098
Pfizer Investigational Site Chaska Minnesota 55318
Pfizer Investigational Site Olive Branch Mississippi 38654
Pfizer Investigational Site St Louis Missouri 63110
Pfizer Investigational Site Lincoln Nebraska 68510
Pfizer Investigational Site Omaha Nebraska 68114
Pfizer Investigational Site Hamilton New Jersey 08690
Pfizer Investigational Site Brooklyn New York 11215
Pfizer Investigational Site Garden City New York 11530
Pfizer Investigational Site Kingston New York 12401
Pfizer Investigational Site Manlius New York 13104
Pfizer Investigational Site New York New York 10016
Pfizer Investigational Site Poughkeepsie New York 12601
Pfizer Investigational Site Burlington North Carolina 27215
Pfizer Investigational Site Cary North Carolina 27518
Pfizer Investigational Site Charlotte North Carolina 28207
Pfizer Investigational Site Concord North Carolina 28025
Pfizer Investigational Site Huntersville North Carolina 28078
Pfizer Investigational Site Salisbury North Carolina 28144
Pfizer Investigational Site Fargo North Dakota 58103
Pfizer Investigational Site Akron Ohio 44311
Pfizer Investigational Site Cincinnati Ohio 45249
Pfizer Investigational Site Columbus Ohio 43214
Pfizer Investigational Site Columbus Ohio 43221
Pfizer Investigational Site Dayton Ohio 45439
Pfizer Investigational Site Westerville Ohio 43081
Pfizer Investigational Site Portland Oregon 97225
Pfizer Investigational Site Bala-Cynwyd Pennsylvania 19004
Pfizer Investigational Site Bridgeville Pennsylvania 15017
Pfizer Investigational Site Lansdale Pennsylvania 19446
Pfizer Investigational Site Philadelphia Pennsylvania 19114
Pfizer Investigational Site Pittsburgh Pennsylvania 15236
Pfizer Investigational Site Sellersville Pennsylvania 18960
Pfizer Investigational Site East Greenwich Rhode Island 02818
Pfizer Investigational Site Pawtucket Rhode Island 02860
Pfizer Investigational Site Warwick Rhode Island 02886
Pfizer Investigational Site Anderson South Carolina 29621
Pfizer Investigational Site Mt. Pleasant South Carolina 29464
Pfizer Investigational Site Bristol Tennessee 37620
Pfizer Investigational Site Kingsport Tennessee 37660
Pfizer Investigational Site Knoxville Tennessee 37920
Pfizer Investigational Site Milan Tennessee 38358
Pfizer Investigational Site Nashville Tennessee 37203
Pfizer Investigational Site New Tazewell Tennessee 37825
Pfizer Investigational Site Bryan Texas 77802
Pfizer Investigational Site Dallas Texas 75231
Pfizer Investigational Site Houston Texas 77024
Pfizer Investigational Site Houston Texas 77030
Pfizer Investigational Site Houston Texas 77079
Pfizer Investigational Site Plano Texas 75024
Pfizer Investigational Site Norfolk Virginia 23502
Pfizer Investigational Site Richmond Virginia 23294
Pfizer Investigational Site Mountlake Terrace Washington 98043
Pfizer Investigational Site Seattle Washington 98104
Pfizer Investigational Site Spokane Washington 99207
Pfizer Investigational Site Menomonee Falls Wisconsin 53051

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00911937, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Dec 3, 2018 · Synced May 4, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00911937 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →